Keyphrases
South African
100%
Antiretroviral Therapy
100%
Hepatitis B Virus
100%
Lamivudine
100%
Hepatitis B
100%
Viremia
100%
Hepatitis B Virus DNA
28%
South Africa
14%
Resource-limited Settings
14%
HIV Patients
14%
Hepatitis B Virus Infection
14%
Viral Load
14%
Nested PCR (nPCR)
14%
Occult Hepatitis B Virus Infection
14%
Co-infected Patients
14%
Antiretroviral Therapy Initiation
14%
Polymerase Chain Reaction Assay
14%
Sequence Analysis
14%
Resistance mutations
14%
Antiretroviral Adherence
14%
Occult HBV Infection
14%
High Adherence
14%
Virus Resistance
14%
Polymerase Gene
14%
Chronic Hepatitis B Virus Infection
14%
Virus Polymerase
14%
Virus Detection
14%
Tenofovir
14%
Chronic HBV Infection
14%
Regular Monitoring
14%
COBAS TaqMan
14%
Genotype G
14%
Dual Therapy
14%
Rare Genotypes
14%
HIV Viremia
14%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Lamivudine
100%
Hepatitis B Virus
100%
Hepatitis B
100%
Viremia
100%
Antiretroviral Therapy
54%
Infection
27%
Virus DNA
18%
Health Care Cost
9%
Antivirus Agent
9%
Nested Polymerase Chain Reaction
9%
Structural Gene
9%
Resistance Mutation
9%
Prospective Study
9%
Sequence Analysis
9%
Protein Sequencing
9%
Chronic Hepatitis B
9%
Tenofovir
9%
Virus Resistance
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Lamivudine
100%
Hepatitis B Virus
100%
Hepatitis B
100%
Viremia
100%
Infection
27%
Virus DNA
18%
Antivirus Agent
9%
Prospective Study
9%
Chronic Hepatitis B
9%
Tenofovir
9%
Virus Resistance
9%